These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7942724)

  • 21. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori.
    Chu KM; Choi HK; Tuen HH; Law SY; Branicki FJ; Wong J
    Am J Gastroenterol; 1998 Sep; 93(9):1436-42. PubMed ID: 9732921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
    Calvet X; García N; Campo R; Brullet E; Comet R; Navarro M
    Am J Gastroenterol; 1998 Jun; 93(6):932-4. PubMed ID: 9647022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eczema responsive to treatment for Helicobacter pylori.
    Wilson WH
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
    Shuter J; Fletcher DD; Simone VJ; Bellin EY
    J Urban Health; 1998 Dec; 75(4):896-902. PubMed ID: 9854250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
    Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
    J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study.
    Ergül B; Koçak E; Taş A; Filik L; Köklü S
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):527-9. PubMed ID: 23312494
    [No Abstract]   [Full Text] [Related]  

  • 33. [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?].
    Calvet X; Gené E
    Gastroenterol Hepatol; 2003 May; 26(5):325-9. PubMed ID: 12732108
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Helicobacter pylori infection: a review.
    Blecker U; Gold BD
    Pediatr Infect Dis J; 1997 Apr; 16(4):391-9. PubMed ID: 9109142
    [No Abstract]   [Full Text] [Related]  

  • 35. Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis.
    Wu C; Chen X; Liu J; Li MY; Zhang ZQ; Wang ZQ
    Helicobacter; 2011 Apr; 16(2):131-8. PubMed ID: 21435091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori eradication: equivalence trials and the optimal duration of therapy.
    Vakil N; Connor J
    Am J Gastroenterol; 2005 Aug; 100(8):1702-3. PubMed ID: 16144122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACP Journal Club. Quadruple-drug therapy was better than triple-drug therapy for eradicating Helicobacter pylori in adults.
    Talley NJ
    Ann Intern Med; 2011 Jun; 154(12):JC6-2. PubMed ID: 21690580
    [No Abstract]   [Full Text] [Related]  

  • 38. Electronic Health Records: a "Quadruple Win," a "Quadruple Failure," or Simply Time for a Reboot?
    Hochman M
    J Gen Intern Med; 2018 Apr; 33(4):397-399. PubMed ID: 29404945
    [No Abstract]   [Full Text] [Related]  

  • 39. Case of Quadruple Birth.
    Wilson J
    Glasgow Med J; 1866 Aug; 1(4):145-146. PubMed ID: 30432613
    [No Abstract]   [Full Text] [Related]  

  • 40. The Effect of Helicobacter pylori Eradication on Gastric Wall Thickness in Patients Undergoing Laparoscopic Sleeve Gastrectomy.
    Ergin A; Çiyiltepe H; Karip AB; Fersahoğlu MM; Bulut NE; Çakmak A; Topaloğlu B; Bilgili AC; Somay A; Taşdelen İ; Akyüz Ü; Memişoğlu K
    Obes Surg; 2021 Sep; 31(9):4024-4032. PubMed ID: 34075550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.